Procyon Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,831	Closed	-$207K	–	524
2023 Q3	$207K	Sell	2,831 -500	-15%	-$39.9K	0.02%	453
2023 Q2	$277K	Sell	3,331 -114	-3%	-$9.53K	0.03%	368
2023 Q1	$263K	Buy	3,445 +519	+18%	+$43.1K	0.04%	328
2022 Q4	$243K	Sell	2,926 -1,198	-29%	-$97K	0.04%	323
2022 Q3	$327K	Buy	+4,124	New	+$348K	0.08%	230
2021 Q4	–	Sell	-1,667	Closed	-$210K	–	354
2021 Q3	$210K	Buy	1,667 +1	+0.1%	+$129	0.05%	303
2021 Q2	$226K	Buy	1,666 +2	+0.1%	+$263	0.06%	268
2021 Q1	$226K	Sell	1,664 -135	-8%	-$20.2K	0.1%	223
2020 Q4	$253K	Buy	+1,799	New	+$230K	0.13%	194
2020 Q3	–	Sell	-791	Closed	-$89K	–	1082
2020 Q2	$89K	Sell	791 -94	-11%	-$9.26K	0.05%	306
2020 Q1	$69K	Buy	885 +110	+14%	+$9.74K	0.05%	288
2019 Q4	$74K	Buy	+775	New	+$67K	0.05%	297